Katherine Stueland
Chief Commercial Officer, Invitae.
Companies
- GeneDx Holdings Corp.Board member May 2, 2022 to now1
- GeneDx Holdings Corp.Chief executive officer May 2, 2022 to now1
- InvitaeChief Commercial Officer Nov 14, 2016 to Jun 16, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GeneDx Holdings Corp. WGS115,476 shares3$7.6M at $66.17Sep 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2026Sold 3,039 shares at $99.00 of GeneDx Holdings Corp.3
- Sep 16, 2026Sold 4,141 shares at $98.27 of GeneDx Holdings Corp.3
- Sep 16, 2026Sold 1,525 shares at $96.90 of GeneDx Holdings Corp.3
- Sep 16, 2026Sold 148 shares at $95.41 of GeneDx Holdings Corp.3
- Sep 16, 2026Sold 1,648 shares at $94.26 of GeneDx Holdings Corp.3
- Sep 16, 2026Exercised options 18,750 shares of GeneDx Holdings Corp.3
- Sep 9, 2026Sold 3,692 shares at $84.22 of GeneDx Holdings Corp.4
- Sep 9, 2026Exercised options 6,547 shares of GeneDx Holdings Corp.4
- Jun 16, 2026Sold 2,429 shares at $61.50 of GeneDx Holdings Corp.5
- Jun 16, 2026Sold 5,932 shares at $60.83 of GeneDx Holdings Corp.5
- Jun 16, 2026Sold 2,140 shares at $59.75 of GeneDx Holdings Corp.5
- Jun 16, 2026Exercised options 18,750 shares of GeneDx Holdings Corp.5
- Jun 9, 2026Sold 3,639 shares at $53.77 of GeneDx Holdings Corp.6
- Jun 9, 2026Exercised options 6,546 shares of GeneDx Holdings Corp.6
- Apr 29, 2026Sold 18 shares at $64.12 of GeneDx Holdings Corp.7
- Apr 29, 2026Sold 2,154 shares at $65.20 of GeneDx Holdings Corp.7
- Apr 29, 2026Exercised options 3,874 shares of GeneDx Holdings Corp.7
- Mar 26, 2026Sold 9,883 shares at $65.21 of GeneDx Holdings Corp.8
- Mar 26, 2026Sold 5,292 shares at $64.60 of GeneDx Holdings Corp.8
- Mar 26, 2026Sold 13,412 shares at $63.28 of GeneDx Holdings Corp.8
- Mar 26, 2026Sold 5,117 shares at $62.33 of GeneDx Holdings Corp.8
- Mar 26, 2026Sold 13,229 shares at $61.29 of GeneDx Holdings Corp.8
- Mar 26, 2026Exercised options 80,000 shares of GeneDx Holdings Corp.8
- Mar 16, 2026Sold 772 shares at $77.94 of GeneDx Holdings Corp.9
- Mar 16, 2026Sold 9,229 shares at $77.05 of GeneDx Holdings Corp.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGeneDx Holdings Corp., Board member
- 2SEC EDGARInvitae, Chief Commercial Officer
- 3
- 4SEC EDGARForm 4 filed Sep 11, 2026
- 5SEC EDGARForm 4 filed Jun 18, 2026
- 6SEC EDGARForm 4 filed Jun 11, 2026
- 7SEC EDGARForm 4 filed May 1, 2026
- 8SEC EDGARForm 4 filed Mar 30, 2026
- 9SEC EDGARForm 4 filed Mar 17, 2026